Antibodies, Monoclonal, Humanized D061067

Chemicals and Drugs [D] » Amino Acids, Peptides, and Proteins [D12] » Proteins » Blood Proteins » Immunoproteins » Immunoglobulins » Antibodies » Antibodies, Monoclonal » Antibodies, Monoclonal, Humanized

Chemicals and Drugs [D] » Amino Acids, Peptides, and Proteins [D12] » Proteins » Blood Proteins » Serum Globulins » Immunoglobulins » Antibodies » Antibodies, Monoclonal » Antibodies, Monoclonal, Humanized

Chemicals and Drugs [D] » Amino Acids, Peptides, and Proteins [D12] » Proteins » Globulins » Serum Globulins » Immunoglobulins » Antibodies » Antibodies, Monoclonal » Antibodies, Monoclonal, Humanized

Description

Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.   MeSH

Hierarchy View

Subtype Terms (21)

Abciximab
 

Adalimumab
3 drugs (2 approved, 1 experimental)

Alemtuzumab
1 approved drug

Basiliximab
 

Bevacizumab
11 drugs (8 approved, 3 experimental)

Brentuximab Vedotin
 

Certolizumab Pegol
 

Cetuximab
8 drugs (5 approved, 3 experimental)

Daclizumab
 

Denosumab
 

Gemtuzumab
 

Inotuzumab Ozogamicin
 

Ipilimumab
 

Natalizumab
 

Nivolumab
1 approved drug

Omalizumab
1 approved drug

Palivizumab
 

Panitumumab
 

Ranibizumab
1 approved drug

Trastuzumab
1 approved drug

Ustekinumab
 

Hierarchy Tree View


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.